ImmunityBio (IBRX) Tax Rate (2015 - 2026)

ImmunityBio (IBRX) posted quarterly Tax Rate of 0.22% for Q4 2025, up 174.6% quarter-over-quarter from 0.29% in Q2 2025.

ImmunityBio (IBRX) Tax Rate (2015 - 2026) Analysis & Trends

ImmunityBio (IBRX) has reported Tax Rate for 10 consecutive years, with 0.22% the latest figure, recorded in Q4 2025.

In Q4 2025, Tax Rate changed N/A year-over-year to 0.22%; the TTM figure through Mar 2026 stood at 0.02% (down 7.0% YoY), while the FY2025 annual figure was 0.04%, changed N/A from the prior year.
Tax Rate advanced to 0.22% in Q4 2025 per IBRX's latest filing, from 0.29% in the prior quarter.
Across five years, Tax Rate topped out at 0.22% in Q4 2025 and bottomed at 0.29% in Q2 2025.
Historically, Tax Rate has averaged 0.01% across 4 years, with a median of 0.0% in 2021.
On a YoY basis, Tax Rate climbed as much as 8 bps in 2021 and fell as far as 30 bps in 2021.
ImmunityBio's Tax Rate stood at 0.0% in 2021, then plunged by 2774 bps to 0.03% in 2022, then soared by 155 bps to 0.02% in 2023, then jumped by 1169 bps to 0.22% in 2025.
Business Quant data shows IBRX's Tax Rate at 0.22% in Q4 2025, 0.29% in Q2 2025, and 0.18% in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	15.11%
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	10.91%
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	24.15%
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-9.47%
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	7.49%
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-16.71%
10	ImmunityBio	7.97 Bn	7.62 Bn	50.94 Mn	-

Download Data